ClearPoint Neuro Ownership | Who Owns ClearPoint Neuro?


OverviewRevenueFinancialsChartTranscripts

ClearPoint Neuro Ownership Summary


ClearPoint Neuro is owned by 47.41% institutional investors, 5.44% insiders, and 47.16% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.05% of CLPT shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.87% of its assets in ClearPoint Neuro shares.

CLPT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockClearPoint Neuro47.41%5.44%47.16%
SectorHealthcare Stocks 50.44%12.38%37.18%
IndustryMedical Device Stocks49.22%12.60%38.18%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de2.38M8.05%$42.46M
Mak capital one2.38M8.04%$42.39M
Vanguard group1.77M6.21%$24.17M
Vanguard capital management1.23M4.17%$21.99M
State street816.55K2.76%$14.57M
Geode capital management749.93K2.54%$13.38M
Lane generational444.83K1.51%$7.94M
Ubs group428.63K1.45%$7.65M
Blackrock366.40K1.44%$1.97M
Millennium management357.68K1.21%$6.38M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Lane generational444.83K6.97%$7.94M
Mak capital one2.38M5.94%$42.39M
Boone capital management283.91K2.03%$6.19M
Cahill wealth management244.42K1.92%$3.76M
Cm management125.00K1.42%$2.23M
Taylor frigon capital management132.01K1.10%$2.36M
Exome asset management83.64K0.92%$1.49M
Conway capital management92.97K0.74%$1.66M
Pier capital222.76K0.53%$3.97M
Gordian capital singapore pte15.50K0.48%$276.52K

Top Buyers

HolderShares% AssetsChange
Mak capital one2.38M5.94%474.37K
Blackrock funding, inc. /de2.38M0.00%297.05K
Boone capital management283.91K2.03%283.91K
Vanguard group1.77M0.00%269.04K
Pier capital222.76K0.53%222.76K

Top Sellers

HolderShares% AssetsChange
Blackrock366.40K--1.11M
Stempoint capital lp---481.86K
Sg americas securities---372.36K
Goldman sachs group138.91K0.00%-324.71K
Essex investment management---232.46K

New Positions

HolderShares% AssetsChangeValue
Boone capital management283.91K2.03%283.91K$6.19M
Pier capital222.76K0.53%222.76K$3.97M
Two sigma advisers, lp132.40K0.01%132.40K$2.88M
Diametric capital, lp123.29K0.23%123.29K$2.20M
Longaeva partners94.91K0.04%94.91K$1.69M

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-4.00
Mai capital management-4.00
Pom investment strategies-15.00
Nisa investment advisors-20.00
Lri investments-42.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202613911.20%14,007,4747.80%472.45%72-2.70%3252.38%
Mar 31, 202662-50.79%4,196,992-62.86%140.94%37-31.48%10-73.68%
Dec 31, 202583-28.45%8,840,955-11.65%312.48%36-37.93%23-14.81%
Sep 30, 20251096.86%9,875,9627.83%343.33%56-11.11%2538.89%
Jun 30, 2025102-3.77%9,154,32911.74%323.71%6214.81%18-40.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF804.25K2.87%-
Vanguard Morn Total Stk Mkt Idx Investor853.80K2.85%-33.70K
Vanguard Total Stock Mkt Idx Inv853.80K2.85%-33.70K
iShares Russell 2000 ETF720.90K2.36%-12.77K
Rolnik Focus FIL500.00K1.64%-
Vanguard Institutional Extnd Mkt Idx Tr351.87K1.17%14.47K
Fidelity Small Cap Index279.73K0.93%5.05K
iShares Russell 2000 Growth ETF258.31K0.85%-2.37K
Invesco Dorsey Wright SmallCap Momt ETF187.18K0.68%-1.34K
Pier Capital Small Cap Growth Equity199.88K0.67%199.88K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 29, 2026BURNETT JOSEPH CEO and PresidentSell$387.60K
Jun 17, 2026BURNETT JOSEPH CEO and PresidentSell$1.07M
Jun 17, 2026BURNETT JOSEPH CEO and PresidentSell$33.06K
Jun 01, 2026Richards Timothy T.-Sell$65.90K
May 21, 2026Klein Matthew B.-Sell$185.44K

Insider Transactions Trends


DateBuySell
2026 Q2-6
2026 Q1-3
2025 Q4-4
2025 Q3--
2025 Q2-4

CLPT Ownership FAQ


Who Owns ClearPoint Neuro?

ClearPoint Neuro shareholders are primarily institutional investors at 47.41%, followed by 5.44% insiders and 47.15% retail investors. The average institutional ownership in ClearPoint Neuro's industry, Medical Device Stocks, is 49.22%, which ClearPoint Neuro falls below.

Who owns the most shares of ClearPoint Neuro?

ClearPoint Neuro’s largest shareholders are Blackrock funding, inc. /de (2.38M shares, 8.05%), Mak capital one (2.38M shares, 8.04%), and Vanguard group (1.77M shares, 6.21%). Together, they hold 22.31% of ClearPoint Neuro’s total shares outstanding.

Does Blackrock own ClearPoint Neuro?

Yes, BlackRock owns 1.44% of ClearPoint Neuro, totaling 366.4K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.97M$. In the last quarter, BlackRock decreased its holdings by -1.108M shares, a -75.14% change.

Who is ClearPoint Neuro’s biggest shareholder by percentage of total assets invested?

Lane generational is ClearPoint Neuro’s biggest shareholder by percentage of total assets invested, with 6.97% of its assets in 444.83K ClearPoint Neuro shares, valued at 7.94M$.

Who is the top mutual fund holder of ClearPoint Neuro shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of ClearPoint Neuro shares, with 2.87% of its total shares outstanding invested in 804.25K ClearPoint Neuro shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools